Healthcare Antitrust, Settlements, and the Federal Trade Commission Vol: 28

James Langenfeld
Navigant Economics, USA

Edwin Galeano
Navigant Economics, USA


List price £77.95 Add to basket
Product Details
Format:
Hardback
ISBN:
9781787566002
Published:
09 Aug 2018
Publisher:
Emerald Publishing Limited
Dimensions:
341 pages - 152 x 229mm
Series:
Research in Law and Economics

Categories:

This volume of Research in Law and Economics contains articles that address important legal and economic developments in the areas of healthcare, intellectual property and labor settlements, competitive effects, cartel overcharges, and the U.S. Federal Trade Commission (“FTC”). Four of the articles were initially presented at a conference on healthcare competition in Washington, D.C., which was sponsored by the American Antitrust Institute, this journal, and Navigant Economics. These articles explore practices that are under challenge in pharmaceuticals, where the Federal Trade Commission has been extremely active, as well as issues involving hospital and health insurance mergers. They are followed by a long and detailed discussion of the current and historic role of economists and economic analysis at the Federal Trade Commission. The next two articles analyze different aspects of the French economy, pre-trial labor settlements and the impact of e-commerce on franchisees. The volume ends with three technical economics articles – one on “upward pricing pressure”, one on estimating price increases in cartel cases, and one critiquing a “meta-analysis” of research on the effectiveness of U.S. merger regulation. Taken together, these articles raise questions about appropriate competition policy, how to evaluate settlements and other firm behavior, and where economics and competition policy are headed.
Introduction
Chapter 1. “TO KNOW WHERE YOU’RE GOING, LOOK AT WHERE YOU’VE BEEN”; Deborah L. Feinstein
Chapter 2. ACTAVIS, AUTHORIZED GENERICS, AND THE FUTURE OF ANTITRUST LAW; Marc G. Schildkraut
Chapter 3. SOLVING THE PRODUCT HOPPING CONUNDRUM THROUGH SAFE HARBORS AND A NO-ECONOMIC-SENSE TEST; Michael A. Carrier and Steve D. Shadowen
Chapter 4. A MARKET ALL ITS OWN: MEDICARE ADVANTAGE AS A SEPARATE PRODUCT MARKET IN THE DOJ’S CASE AGAINST THE AETNA-HUMANA MERGER; Douglas Ross and David Maas
Chapter 5. A HISTORY OF THE FTC’S BUREAU OF ECONOMICS; Paul A. Pautler
Chapter 6. LABOR DISPUTES AND PRETRIAL SETTLEMENTS: THE FRENCH CASE; Jean-Christian Tisserand
Chapter 7. FRANCHISEES FACING ONLINE SALES IN A EUROPEAN LEGAL CONTEXT; Guy Basset, Rozenn Perrigot, and Gerard Cliquet
Chapter 8. MANDATORY UPSTREAM INPUTS AND UPWARD PRICING PRESSURE: IMPLICATIONS FOR COMPETITION POLICY; Timothy J. Tardiff and Dennis L. Weisman
Chapter 9. WHEN IS THE “KENNEDY CORRECTION” APPROPRIATE IN ESTIMATING OVERCHARGES?; Wenqing Li and James F. Nieberding
Chapter 10. KWOKA’S MERGERS, MERGER CONTROL, AND REMEDIES: REJOINDER TO KWOKA; Michael Vita

You might also be interested in..

« Back